Transaction in Own Shares

Foresight Group bought back 50,000 ordinary shares across 2–8 October 2026, with daily volume-weighted average prices ranging from 431.635650p to 456.829600p. The shares will be held in treasury with no voting rights; the programme has repurchased 7,628,732 shares in total, leaving 111,181,960 shares with voting rights out of 112,347,803 issued.

Analysis

This is a small, mechanical capital-return signal, not evidence of a valuation floor: the five sessions add roughly £225k of purchases, about 0.045% of voting shares. The buyback did not prevent the share price from weakening over the period; treat it as modest marginal demand rather than downside protection. Treasury treatment also matters: shares are not cancelled, so future reissue could dilute the apparent per-share benefit. The stated cumulative programme purchases materially exceed the current treasury balance, so reconcile cancellations or reissuance before using programme totals to estimate capital returned.

For Foresight Group, the more consequential medium-term drivers are likely fundraising, fee-bearing AUM, realizations and investment performance across its real-asset strategies—not this week’s execution. A sustained discount or continued price weakness despite the programme could indicate investors are questioning those drivers, while buybacks may compete with investing in growth or maintaining balance-sheet flexibility. Over 1–3 months, monitor programme pace, cash generation and any AUM/fee guidance; over 6–18 months, realized returns and fundraising determine whether capital returns are durable. No competitor read-through is warranted from this routine notice.

Key Decisions for Investors

• No standalone trade on the disclosure. Do not treat the daily purchases as a price put; the disclosed volume is too small to materially alter supply or valuation.
• For an existing FSG position, monitor the next results for fee-bearing AUM, fundraising, realizations and cash available after commitments. A deterioration in those measures would outweigh continued small buybacks.
• Before crediting cumulative repurchases to per-share value, verify the number of shares cancelled, reissued and currently held in treasury, and whether the programme has a remaining spending or volume limit.
• Reassess the neutral stance if FSG continues to weaken while buybacks persist and management lowers operating or fundraising expectations; the thesis improves only if cash generation and shareholder returns are supported by reported fundamentals.